Boehringer sues Indian manufacturer over diabetes drug generic

German pharma giant claims Granules India’s ANDA infringes five patents I Combination therapy Jentadueto among Boehringer’s top three products in 2023.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Drug approvals up but global innovation declines

26 September 2024 WIPO’s Global Innovation Index reveals most innovative nations | Higher-value inventions attracting investors in a more difficult climate | Switzerland retains most innovative economy spot with India’s ‘exciting’ growth a highlight.

Unified Patent Court

‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute

26 September 2024 Cameron Marshall, partner at Carpmaels, offers a behind-the-scenes snapshot of working a UPC case with tight deadlines and an unusual result, finds Sarah Speight.

Americas

Novo Nordisk files fresh lawsuits to intercept Wegovy generics

11 September 2024 Danish multinational asks Delaware court to block semaglutide generics from Sun Pharma and Mylan | ANDAs infringe two claims of patent granted in July, Novo claims.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Boehringer sues Indian manufacturer over diabetes drug generic

More on this story

Editor's picks

Editor's picks

More features